The Risk of overlooking thyroid cancer in radioiodine treatment of hyperthyreosis and goiter - PowerPoint PPT Presentation

1 / 12
About This Presentation
Title:

The Risk of overlooking thyroid cancer in radioiodine treatment of hyperthyreosis and goiter

Description:

The Risk of overlooking thyroid cancer in radioiodine treatment. of hyperthyreosis and goiter ... it seems that we don't overlook cancer if we use scintiscan, ... – PowerPoint PPT presentation

Number of Views:197
Avg rating:3.0/5.0
Slides: 13
Provided by: andersve
Category:

less

Transcript and Presenter's Notes

Title: The Risk of overlooking thyroid cancer in radioiodine treatment of hyperthyreosis and goiter


1
The Risk of overlooking thyroid cancer in
radioiodine treatment of hyperthyreosis and
goiter
  • Anders Vej-Hansen (1), Lars Thorbjørn Jensen (2),
  • Kaj Siersbæk-Nielsen (3) og Birte Nygaard (1)
  • 1) Dep. of Endocrinology, Herlev Hospital, 2)
    Dep. of Clinical Fysiology, Glostrup Hospital, 3)
    Dep. of Endocrinology, Frederiksberg Hospital,
    Denmark

2
Introduction
  • About 3,000 patients are treated with radioiodine
    in Denmark for thyroid diseases each year
  • Alternative treatment is surgery but radioiodine
    is more gentle
  • Evaluation strategy includes bloodsamples and a
    scintiscan

3
Previous studies
4
Purpose
  • To evaluate if the evaluation strategy is good
    enough to exclude thyroid cancer

5
Materials and methods
  • We collected information about all patients
    treated with radioiodine in 3 centre hospitals in
    Copenhagen
  • Information was compared with information on
    reported thyroid cancers in the national cancer
    register

6
Results I
 
7
Results II
 
8
Description of the cancers
No. Goiter Age Time to Time
to Age Sex -type RI cancer death death Patol
ogy 1 M Tox dif 61,2 -6,11- -0,5- 68,6 Anap
lastic 2 F Tox nod 82,8 -0,2- -0,2- 83,0 Unkn
own 3 F Tox nod 80,7 -4,5- -3,5- 88,5 Follicu
lary 4 M Tox nod 73,9 -0,8- -0,2- 74,7 Anapl
astic 5 F Tox nod 77,7 -7,0- -4,10- 89,5
(alive) Papillifery 6 F Tox nod 75,9 -2,8- -2,0
- 80,5 Anaplastic 7 M Atox nod 59,8 -4,5- -0,
1- 64,2 Folliculary 8 F Tox nod 53,9 -4,2- -1
,8- 59,7 (alive) Papillifery
9
Discussion
  • We have found more cancers than expected from the
    background population
  • The cancer incidence is at the same level as
    earlier described in studies of patients with
    hyperthyreosis treated with medicine, surgery or
    radioiodine

10
Previous studies
11
Conclusion
  • In this study it seems that we dont overlook
    cancer if we use scintiscan, and when it shows a
    cold nodule, we do a biopsy
  • This is also the evaluation of patients with
    nontoxic goiter

12
Thank You!!!
  • Anders Vej-Hansen, Lars Thorbjørn Jensen, Kaj
    Siersbæk-Nielsen og Birte Nygaard
Write a Comment
User Comments (0)
About PowerShow.com